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Botulism Is a very rare, but highly fatal disease caused 
by the Ingestion of a specific antigenic exotoxin produced by 
Clostridium botullnum. To date six antigenically distinguish­
able toxins have been Identified and are labeled A, B, C, D, E 
and P (Lamanna and Carr, 1967). These materials are neuro­
toxins which paralyze certain motor nerves in animals by 
suppressing the release of acetylcholine at the cholinergic 
synapses (Brooks, 195^; Mitchell and Silver, I963). Extremely 
small quantities of toxin are required to kill animals. 
Putnam e;fc aJ., 1946 estimated that the lethal dose for mice 
was 20 million molecules of type A toxin. The specific 
toxicities range from 0.6 x 10^^ to 3.8 x 10^^ per gram of 
toxin (Schantz, 1964). Chemical characterization of the 
toxins indicated they are simple proteins composed entirely 
of amino acids (Buehler .^, 1947; Lamanna and Carr, 1967). 
The fate of botulinal toxin within bodies of animals has been 
studied by many workers (Dack, 1926; May and Whaler, 1958; 
Hildebrand _et ^., 1961). In these studies toxin was detected 
in animal tissues by bloassay methods. Zacks _et al, (1962) 
used ferritin labeled botulinal toxin and electron microscopy 
to demonstrate localization of toxin in neuromuscular junctions 
of mice. Iodine 131 has been used successfully to radlolabel 
proteins used for vivo and jji vitro studies (Masouredis 
£t al,, 195I; Tekman and Dalglish, 1954; Melcher _et ^., 1955; 
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Francis ejt 1955a, 1955b; Welgle and KLxon, 1959; Weigle 
 ^aJ., i960). Klrilenko ^  aJL. (1965) reported on results 
of experiments in which tetanal toxin was radiolabeled with 
iodine 131 and then injected into mice. The animals were 
sacrificed at selected time intervals and the major organs 
and tissues of the animals were analyzed in a radiation 
counter. The assumption was made that radioactivity in 
tissues demonstrated the presence of toxin. Radioactivity 
counted at selected time intervals yielded absorption patterns 
for the tissues examined. These authors made no attempt to 
compare the distribution patterns obtained for tetanal toxin 
with patterns for similarly treated non-toxic proteins. 
The main purpose of this work was to compare the fate of 
radiolabeled botullnal toxin in animals with the fate of non­
toxic proteins which were radiolabeled -and introduced into 
rats in identical fashion as the toxin. This was done to 
determine if any differences existed between distribution 
patterns established for perltoneally inoculated toxic and 
non-toxic proteins. 
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REVIEW OP LITERATURE 
The Organism and Toxin Production 
Botulism Is a true food poisoning caused by the Ingestion 
of food containing toxin produced by Clostrldum botullnum 
(Prazler, 1967). For centuries eating of certain preserved 
foods has been related to the Incidence of botulism. 
Botulism was recognized by German physicians as a specific 
food illness in the latter part of the eighteenth century 
(Dolman, 1964). The organism responsible for botulism was 
isolated in 1894 by a Belgian physician named van Ermengen 
(Dolman, 1964). According to Bengston (1924) van Ermengen 
described the organism as being a large sporeformlng bacillus, 
4 to 6 microns in length, 0.9 to 1.2 microns wide and as 
having rounded extremities. The spore was described as being 
generally terminal and somewhat wider than the rod and 
resistant to ordinary staining reactions. Motility was slight 
and there were four to eight very fine flagella. The 
organism gave a positive gram staining reaction. The 
bacterium was characterized as being a strict anaerobe which 
grew on glucose agar produced turbidity and gas in glucose 
broth, but not in lactose or sucrose broths. Gelatin was 
liquified, but milk protein was not coagulated or otherwise 
changed. The unpleasant odor of butyric acid occurred in 
various media. Acid media prevented growth, while slightly 
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alkaline media encouraged growth and toxin production. The 
optimal growth temperature was In the range of 20 to 30 C. 
Filtrates of foods in which _C. botullnum had grown killed 
guinea pigs and mice when administered orally. Certain 
animals such as dogs, cats, chickens and rats withstood more 
toxin than did mice, guinea pigs and rabbits. 
Van Ermengen originally suggested the name Bacillus 
botullnus for this organism. Bengston (1924) studied 15 
strains of these organisms and suggested the names Clostridium 
botullnum and Clostridium parabotullnum. The seventh edition 
of Bergey's Manual of Determinative Bacteriology (1957) 
suggests that the name _C. botullnum be applied to non-ovolytic 
strains of the organism and Ç. parabotullnum be applied to 
ovolytic strains. 
Bengston (1924) grouped C_. botullnum into types based on 
serological reactions of their toxins. To date six antlgenl-
cally distinguishable toxins have been identified and are 
designated A, B, C, D, E and P. Type C toxin can be further 
divided into subtypes alpha and beta. Each toxin type is 
antigenlcally unique and very little cross neutralization is 
observed between toxin types and specific antitoxin. Anti­
toxin type C subtype alpha protects against subtype beta, but 
the Inverse is not true (Lamanna and Carr, I967 ). 
Much work has been done on determining the effect of 
temperature, pH and salt concentration on the growth of 
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C. botullnum. and toxin production. The present discussion 
will be limited to _C. botullnum types A, B, E and P, which are 
generally regarded as the causative agents of human botulism. 
In general, the optimal "temperature for growth and toxin 
production of _C. botullnum types A and B is in the range of 
20 to 30 C (Dolman, 1964). Ohye and Christian (1966) reported 
that _C. botullnum type A and B grew at temperatures ranging 
from 20 to 40 C. and type E grew in a range of 10 to 40 C. 
The optimal temperatures for growth and toxin production of 
types A and B were reported by these authors to be 40 C, while 
the optimal temperature for type E was reported to be 35 C. 
Dolman (1964) and Riemann (1963) reported that botullnum 
type E was able to grow and produce toxin after 8 weeks 
Incubation at 5 to 6 C. The probable lower limit of growth 
was suggested to be 2 C. 
Ohye and Christian (1966) observed growth of these three 
types of £. botullnum at pH 6.0, J.O and 8.0; none of the 
three types, however, demonstrated growth at pH 5.0 or 9.0. 
The optimal pH for types A, B and E was reported to be in the 
range of pH 7 to 8. At optimal temperature and pH appreciable 
differences were observed in the water requirements of the 
three types. The minimal levels of water activity (a^) 
supporting growth were reported to be 0.950, 0.940, and 0.970 
for types A, B, and E respectively. These values correspond 
to NaCl concentrations of 8.0^, 9.4^ and 5.1^. The effect 
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of lowered Incubation temperature was to elevate water require­
ments for all three types. The pH at which NaCl tolerance 
was greatest was reported to be 7.0 for types A and B. The 
growth and toxin production of type E were reported to be more 
adversely affected by low temperature in combination with high 
salt concentrations and low pH than was the growth of types A 
and B. Segner ^  (1966) reported that NaCl in concentra­
tions of 4.5^ to 5.0^ were generally sufficient to inhibit 
growth of _C. botullnum type E. The lower concentration of 
NaCl was required to Inhibit growth when the organism was 
incubated at 8 C and 10 C, while a concentration of 5^ NaCl 
was required to inhibit growth of organisms incubated at 30 C. 
The organism did not exhibit growth at pH values below 5.03. 
These data contradict earlier reports by Dolman (1964) that 
Ç. botulinum type E was able to grow in NaCl concentrations 
as high as 10^ in an acid medium below pH 4.5. 
Walls (1966) reported that C. botulinum type P is capable 
of growth and toxin production at temperatures as low as 4 C. 
The optimal temperature for growth and toxin production for 
type P is reported to be 30 C. 
Heat resistance of spores of C_. botulinum has been of 
great concern to investigators for many years. Esty and 
Meyer (1922) did much of the early work on determining 
accurately the thermal resistance of botulinal spores and their 
work was used as a basis for setting up standards for thermal 
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processing of foods. Ito _et (1966) reported that the D 
values of _C. botullnum type A strain 62 A and I2885A at 112.8 C 
were 1.23 minutes and I.09 minutes, respectively; type B 
strains 213 B and 32B had D values of 1.32 minutes and 0.I5 
minutes, respectively when heated at the same temperature of 
112.8 C. Type E when heated at 77.0 C gave D values of 
1.95 minutes, 1.55 minutes, 1.23 minutes and 0.77 minutes for 
strains Saratoga E, Minneapolis E, 1304 E and 8E, respectively. 
Type E botulinal spores are destroyed in a fraction of a 
minute at 100 C and their rate of destruction need not be 
considered in calculating process times and temperatures 
designed to kill the more heat resistant types A and B 
(Perkins, 1964). 
Chemical Nature of Botulinal Toxin 
Five of the six types of botulinal toxins have been 
obtained in relatively pure form. These five types are A, 
B, C, D, and E. Type P has not yet been obtained in a highly 
purified form. Most of the chemical characterization of 
botulinal toxin has been done with type A since it is the only 
one available in crystalline form. Toxin types B, C, D, and 
E have been observed in amorphous form only (Schantz, 1964). 
Type A botulinal toxin was found by Buehler (1947) 
to be composed entirely of amino acids and, therefore, the 
toxin is classified as a simple protein. They reported that 
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Table 1. Comparison of some properties of purified prepara­
tions of botulinal toxin (Schantz, 1964) 
Type Molecular weight Specific Toxicity Isoelectric 
LD^ Q per gram point 
A 900,000^ 
00 CO 
X 10^0 pH 5.6* 
B 
E 
60,000^  „ 







10^° pH 5.6 
^Putnam _et 1946. 
^Lamanna and G-lassman, 194?. 
°Gerwing e_t I966. 
'^Wagman and Bateman, 1951. 
^Gerwing et 19^1. 
D^uff- et aA., 1956. 
the total nitrogen content for type A toxin was l6.2^ and the 
total sulfur content was 0.436^. The amino acid content of 
botulinal toxin types A and B is summarized in Table 2. 
Some workers have attributed toxicity to the presence of 
certain key amino acids. Boroff ^  (1966) proposed that 
tryptophane residues in the molecule are critical to the 
maintenance of reactive sites responsible for toxicity, and 
that these residues might also be involved as antigenic deter-
minents in the formation of antitoxin. Lamanna and Carr (1967) 
point out that purified botulinal toxin type B does not 
possess tryptophane. If it were the key amino acid responsible 
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Table 2. Amino acid composition of toxins (Lamanna and Carr, 
1967) 
Amino acid Botulinal toxin 
Type A Type B 
fo Residues fo Residues 
Glycine 1.05 166 5.50 5 
Alanine 3.12 394 4.57 4 
Valine 4.45 506 4.39 4 
Leucine 8.91 708 7.06 7 
Isoleucine 10.33 820 7.38 7 
Serine 3.60 374 7.07 7 
Threonine 7.19- 642 4.92 5 
Aspartic acid 17.34& 1,370 16.00 16 
Glutamic acid 13.67 953 7.13 7 
Lysine 6.78 477 6.38 6 
Histidine 0.91 60 0.61 1 
Arginine 4.14 239 2.10 2 
Proline 2.19 203 2.39 3 
Phenylalanine 1.04 64 4.35 4 
Tyrosine 12.18 672 4.14 4 
Tryptophane 1.69 82 
1.88 Methionine 0.93 64 2 
Cysteine 0.23 20 1.02 1 
Half cystine 0.45 40 
Total kinds 19 
7,754 
17 
Total moles 85 
% amino acids 100.20 86.9 
Total amide ammonia 2.13 
Molecular weight 894,589 9,531 
^Calculated as asparagine. 
for biological activity of botulinal toxin it would be 
expected to appear in all types of the toxin. Dolman and 
Gerwing (1966) have suggested cysteine may be a key amino 
acid in type E toxin. The -SH groups make cysteine a very 
active amino acid, except at acid pH level, where botulinal 
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toxins likewise tend to be stable. Versene, a chelating agent 
that protects -SH groups from reacting with cations, was found 
to be an Important aid in maintaining biological activity of 
type E toxin. Since cysteine residues are found in toxin 
types A, B, and E, the authors concluded that if a cysteine-
specific reagent were found to destroy the biological activity 
of these toxins, it would follow that this amino acid must be 
critically Involved in the biological activity of the toxin. 
Attempts have been made to explain the high toxicity of 
the botulinal toxin molecule on the basis of arrangement of 
amino acids. Schantz _et (i960) reported that type A toxin 
in pure form will fluoresce when excited by ultraviolet light. 
When the toxicity is lost the fluorescence of the molecule 
is lost as well. This suggested that the structure responsible 
for toxicity was also responsible for its fluorescence (Boroff 
and Fitzgerald, 1958). Schantz ^  (i960) reported that 
if the toxic activity of the molecule is destroyed in 6 M 
urea, fluorescence is not lost. The suggestion that 
fluorescence and toxicity were due to a common structure 
within the molecule was invalidated by this finding. 
Cartwright and Lauffer (1958) observed that type A toxin 
is stable at 40 G in a solution adjusted to pH 6.9, but that 
the toxicity is lost in a matter of minutes at 50 C. A 
strongly alkaline pH destroys the toxin rapidly with 90^  
of the toxin being destroyed in 1 to 2 minutes at pH 11.2 
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(Spero, 1958). Ketene (Schantz and Spero, 1957) halogens 
(Brazis ejt 1959) nitrous acid (Spero and Schantz, 195?) 
protein dénaturants (Stefanye _et a^., 1964) formaldehyde 
and photooxldants (Well £t _al., 1957) are all agents which 
have been shown to destroy or alter the biological activity 
of the botullnal toxin molecule. 
Lamanna and Carr (1967) concluded that the toxicity of 
botullnal toxin cannot be attributed to a single amino acid. 
Destruction or modification of one of a number of amino acids 
could result In loss of biological activity. The toxin appears 
to be a single polypeptide chain without prosthetic groups 
whose maintenance of integrity of tertiary structure appears 
necessary for toxicity. 
The question arises whether a molecule as large as that 
of type A botullnal toxin with a molecular weight of 900,000, 
can pass through the intestinal barrier. Sedimentation coeffi­
cients determined for crystalline type A toxin before and after 
exposure to residence in the small intestine of a rat gave 
no evidence that the toxin in the Intestine broke down into 
smaller sized particles or sub-units before passing the 
intestinal barrier (Heckly e_t , 1960). Wagman and Bateman 
(1951) demonstrated with the aid of an ultracentrifuge that 
under proper conditions of ionic strength and pH, toxin 
molecules disassociate to form smaller toxic sub-units with 
a molecular weight of 40,000 to 100,000. Wagman (1954) 
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reported an estimated molecular weight of the toxic sub-unit 
based on the sedimentation rate in an ultracentrifuge to be 
10,000 to 20,000. A dialyzable toxic unit with a molecular 
weight of 3,800 was obtained from a pepsin digest by Wagman 
(1963). Gerwing et al. (1963) used electrophoresis and ultra-
centrifigation to obtain a homogeneous type A toxic unit with 
a calculated molecular weight of 12,000. Chromatographic 
separation on DEAE cellulose has given molecular weights of 
12,000, 9,000 and l8,600 for types A, B and E respectively 
(Gerwing _et , 1964, 1965, 1966). 
Gerwing £t al. (1965) suggested that purification proce­
dures used to obtain pure toxin for molecular weight deter­
minations may cause low molecular weight toxin to polymerize 
into an aggregate of much larger molecular weight. Schantz 
and Spero (1966) argue strongly against this premise. They 
reported estimates by ultracentrifigation of the molecular 
weight of type A toxin was the same in culture as that of 
purified toxin (900,000) and that all other types B through P 
also must have molecular weights that approach the weight of 
type A. 
Lowenthal and Lamanna (l95l) and Lamanna and Lowenthal 
(1951) reported that botulinal toxin type A was closely 
associated with a hemagglutinating component which was separ­
able from the toxin. Meyer and Lamanna (1959) suggested that 
preparation of botulinal toxin type A on DEAE cellulose may 
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completely separate the hemagglutlnatlng' component from the 
toxin molecule. Removal of the hemagglutlnatlng component 
would yield a toxin with a lower molecular weight. 
Duff e;t (1956) reported that hotullnal toxin type E 
was unique in that its full biological activity was not 
attained until It reacted with trypsin. This activation 
phenomenon was reported by Sakaguchl and Sakaguchl (1966) 
to be the result of conversion of an Inactive precursor into 
the fully toxic molecule by the action of trypsin. Activation 
with trypsin resulted in a 200 fold increase in toxicity, 
but prolonged exposure to trypsin resulted in destruction of 
the biological activity of the type E molecule. The nitrogen 
content and molecular weight, were the same for both the 
precursor and the trypsin-activated type E toxin. Bulatova 
(1965) reported that the precursor of type E toxin was 
serologically indistinguishable from the trypsin-activated 
toxin. Botulinal toxin type P is also reported to be activated 
by trypsin (Holdeman, 1966). 
Pharmacological Action 
The symptoms of botulism begin I8 to 96 hours after 
ingestion of the toxin and Include: visual disturbance (lack 
of coordination of eye muscles, and double vision) inability 
to swallow and speech difficulty. Signs of bulbar paralysis 
are progressive and death occurs from respiratory paralysis. 
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or cardiac arrest. No fever is present. Gastrointestinal 
symptoms are not prominent. The patient remains fully conscious 
until shortly before death (Jawetz 1962). 
The toxin apparently suppresses the release of acetyl­
choline at the cholinergic synapses (Brooks, 195^; Mitchell 
and Silver, 1963). Lamanna and Carr (1967) reported that the 
toxin produces some lesion at the myoneural junction which 
renders it incapable of releasing acetylcholine in quantities 
sufficient to evoke a contraction of muscle fibers. Poisoned 
nerve terminals retain their normal content of acetylcholine 
but are prevented from releasing it from its binding sites, 
Botulinal toxin does not inhibit the release of cholinesterase. 
Transmission of nerve impulses across individual synapses 
becomes impaired after an initial time lag of 20 minutes from 
the time the synapses come into contact with the toxin. 
Once the blockage of the nervous junction becomes complete it 
is irreversible by any known procedure (Brooks, 1954). 
Recovery from chronic botulism poisoning takes months for 
autonomic ganglia and muscle ganglia (Burgen _et , 1949). 
Botulism is characterized by its peripheral effects; the central 
nervous system seems to continue to function normally. The 
antigenic difference in the six types of toxin are reflected 
only in the animal species susceptibility, not in the mode of 
action of the toxins (Brooks, 1964). 
Guyton and MacDonald (19^7) reported that localized 
paralysis had been produced in lower hind leg muscles of 
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guinea pigs and rabbits by Injections of small doses of 
botulinal toxin. Closed intra arterial injections of 
acetylcholine evoked an immediate contraction of paralyzed 
muscles. 
Putnam _et (1946) reported that for type A toxin the 
mouse lethal dose may be as little as 20 million molecules. 
Toxicity for a single type of toxin varies from one species 
of animal to another. The method by which the toxin gains 
entrance to the animal's body also affects the toxicity. 
Lamanna and Carr (1967) estimated that the oral dose of 
purified type A toxin may be 1000 times less toxic than an 
equal amount of purified toxin inoculated Intraperitoneally 
into man, 
Davie s _et (1953) reported on the comparative 
lethalities of botulinal and tetanal toxins when inoculated 
intravenously and directly into the medula oblongata portion 
of a rabbit's central nervous system. Botulinal toxin was 
found to be less toxic when inoculated directly into the 
rabbit's brain than when injected directly into the venous 
circulation. The opposite was true for tetanal toxin. 
Dack (1926) found little toxin in the blood of rats which 
had been fed large doses of botulinal toxin. May and Whaler 
(1958) reported that when botulinal toxin was administered 
orally to rats and rabbits it was absorbed much more rapidly 
from the upper portion of the small intestine than from the 
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lower region of the intestine or from the stomach. In rabbits 
toxin migrated Into the circulatory system by way of the 
thoracic lymph duct. Cannulatlon of the intestinal lymph 
duct and continuous collection of lymph following oral 
ingestion of toxin by rats gave partial or complete protection 
from toxemia, 
Hildebrand ^  a^. (1961) reported that in rabbits which 
were given type A botulinal toxin intravenously and which 
died rapidly from acute poisoning, the toxin was found in 
lymph and plasma with no tendency to diffuse into the 
erythrocytes. Toxin appeared in small quantities in urine and 
bile. Cerebrospinal fluid was generally free of toxin. 
There is some indication that multiple Injections of 
sublethal doses of type A toxin into guinea pigs, rabbits and 
mice produced death when the total dose was significantly 
smaller than one single lethal dose. Impairment of some 
general metabolic functions elicited by small sublethal doses 
of toxin may explain these observations (Matveev, 1959a-; 1959b). 
When administered orally, purified toxin is less toxic 
than toxin which is contained in a complex mixture such as in 
food, Coleman (1954) has suggested that purified toxin is 
probably more easily denatured by the digestive processes of 
an animal than impure toxin because of the loss of protective 
colloids from the pure toxin. 
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MATERIALS AND METHODS 
Sources of Toxin and Antitoxin 
Purified type A botullnal toxin was obtained from Dr. 
Edward Schantz, U.S. Army Biological Laboratory, Port Detrick, 
Md. The toxin was received in two forms; one dissolved in 
0.05 M sodium acetate buffer at pH 4.2 with a concentration 
of 3 nig of toxin per ml, and the other in the lyophillzed 
state. The lyophillzed toxin was prepared from a solution of 
purified toxin in 0.05 M sodium phosphate buffer, pH 6.8. 
Type A equine antitoxin was obtained from the U.S. Public 
Health Service Communicable Disease Center (CDC) Atlanta, 
Georgia. This antiserum was received in the lyophillzed state 
and was rehydrated in a 1:1 solution of sterile glycerin and 
distilled water. After rehydration the preparation contained 
10 International Units of antiserum per ml. An International 
Unit (l.U.) is defined as the specific activity contained in a 
known weight of dried antitoxin for each _C. botullnum type; 
the weight for type A is O.I36O mg. (Bowmer, I963). 
Radlolabeling of Proteins 
Crystallzed and lyophillzed bovine serum albumin (BSA) 
(Sigma Chemical Co., St, Louis, Mo.) fraction V rat serum 
albumin (RSA) (Pentex Incorp., Kankakee, 111.) and purified 
type A botullnal toxin were radiolabeled by a method similar 
to that described by Klrilenko £t (1965). A volume of 
0.1 ml of a solution of sodium iodide 13I (Nuclear Chicago 
catalog no IBS-3, Des Plaines, 111.) was placed in a small 
glass test tube. A small crystal of elemental resublimed 
iodine was added to the solution of iodide and allowed to 
react for 20 minutes at 37 C. An isotropic exchange reaction 
took place during this time which allowed the formation of 
free iodine 131. The solution containing the free radioiodine 
was then drawn off with a micropipette. A volume of 50 
microliters was added to 1 ml volumes of the proteins pre­
viously mentioned. The proteins were dissolved in Bacto-FA 
buffer pH 7.2 (Difco Laboratories, Detroit, Mich.). The 
protein solutions and iodine were allowed to react together 
for 4 hours at 4 C. Separation of unbound iodine was 
accomplished by filtration of the protein solution through a 
column 30 cm in length packed with Sephadex G50, fine 
(Pharmacia, Uppsala, Sweden) which was swelled in the same 
phosphate buffer used to dissolve the proteins. The protein 
material was placed on the column and then eluted with 
phosphate buffer, pH 7.2, flowing at a rate of 0.5 ml per 
minute. Tv;o ml fractions were collected manually using a 10 
ml graduated cylinder. The two ml aliquots were placed in 
glass tubes, 15 x 2.5 cm, (Picker Nuclear, Minneapolis, Minn.) 
and counted in a Picker Autowell II gamma radiation counter. 
The count rate was plotted against the number of milliliters 
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collected. The absorbance of the eluted material at 280 mu 
was measured on the Beckman DU, The absorbance values were 
plotted against the number of milliliters collected. 
One ml of the radiolabeled complex collected from the 
column was precipitated with cold 3^ trichloroacetic acid. 
The precipitated material was centrifuged at 12,350x G for 30 
minutes at 2 C in an RC2-B refrigerated centrifuge (Sorvall, 
Norwalk, Conn.) to insure complete separation of the precipitate 
from the supernatant. Both the precipitate and the supernatant 
were transferred to counting tubes and assayed for radio­
activity. 
Elimination Rate Determination 
The rate at which radiolabeled toxin was eliminated 
from rats was determined by feeding the animals the radio­
labeled material and then collecting all their excretory 
products for a period of time. Sublethal doses of radio­
labeled toxin were placed on pieces of dry bread which were 
then coated with a thin layer of peanut butter. The toxic 
peanut butter sandwich was then fed to a rat which had 
fasted for 24 hours. This determination was performed on a 
pair of rats which were treated identically. After they had 
eaten the toxic sample the rats were placed in metabolism 
cages as shown in Figure 1. Urine and feces samples were 
collected at 12 hour Intervals for a period of 48 hours and 





placed in counting tubes. A volume of radioactive toxin 
equal to the volume consumed by each rat was also placed in 
a counting tube. This reference sample as well as the 
excretory samples were counted in the Picker gamma counter. 
The samples were counted in the same manner as the tissue 
samples. The counts were corrected for decay factor in the 
same manner as subsequently described. The counts for each 
12 hour sampling of urine and feces were added together to 
obtain the total amount of radioactivity excreted by each 
animal within the 12 hour time interval. This totaled 
count was then divided by the count obtained for the 
reference sample to obtain the percent of radioactive 
material lost by excretion during each time interval. 
The effect of passive immunity on the rate of toxin 
elimination was determined by injecting 0.8 lU of type A 
antiserum into the hind leg muscles of two rats 24 hours 
prior to feeding them toxic peanut butter sandwiches. The 
balance of this experiment was identical to the procedure 
described previously. 
Samples of urine from both immune and non-immune rats 
were treated with cold yfo trichloroacetic acid and incubated 
at 4 C for two hours. The samples were spun at 12,000 x G 
for 30 minutes at 2 C in the Sorvall RC2-B centrifuge. The 
supernatant fluid was separated from any precipitate that 
was formed. Supernatant and precipitated material were 
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transferred to counting tubes and radioactivity assayed In 
the Picker counter. This procedure was used to determine if 
any of the radioactive material excreted in the rat's urine 
was in protein form. 
The differences in excretion rates between rats which 
had been fed a radiolabeled protein and intraperltoneally 
inoculated with the same material were also determined. 
Two rats were fed peanut butter sandwiches on which radio­
labeled bovine serum albumin had been placed. These animals 
were then placed in metabolism cages and their urine and 
feces collected and counted for a period of 48 hours. A 
second pair of rats was Inoculated perltoneally with an 
equivalent dose of radiolabeled bovine serum albumin and 
then placed in metabolism cages. The counts from the 
excretory products were divided by the weight of the excreta 
in order to obtain the specific count for the excretion 
products. 
LD^Q Determinations 
The bloassays were run to determine the amount of 
loss of toxicity of the botulinal toxin during the radio-
labeling procedure. A toxic solution was divided into two 
equal parts, one part was radiolabeled with Iodine 131, the 
other was not. The unlabeled toxic sample was then filtered 
through a 30 cm column packed with Sephadex G 50. The 
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buffer system and flow rate were identical as that described 
previously. Five ml fractions were collected manually using 
a 10 ml graduated cylinder. The fraction starting with the 
15th milliliter and stopping with the 20th milliliter 
contained most of the proteinaceous material. This fraction 
was saved and used for the determination. The column 
was washed for several hours with phosphate buffer to insure 
removal of all protein material. The radiolabeled sample 
was then put on the column and eluted. The same fraction 
was saved and used for the LD^Q determination. Both samples 
were diluted in ten fold dilutions with physiological saline. 
The dilutions ranged from 10° to 10~9, Five albino mice 
per dilution were peritoneally inoculated with 0.5 ml of 
toxic material. Non-radiolabeled and radiolabeled toxin 
were inoculated in this manner into 50 animals for each of 
the two toxin groups. The animals were observed for 96 
hours and LD^Q values were calculated using the method of 
Reed and Muench (1938). 
Toxin Recovery from Tissues 
A lethal dose of radiolabeled toxin was inoculated 
peritoneally into two white rats. Following death of the 
animals, the brain, lymph node in the neck, thyroid gland, 
blood, heart, lung, liver, spleen, kidney, stomach, small 
intestine, spinal column and tail were removed from each 
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animal and weighed. The tissues were counted in 
the Picker counter in the same manner as subsequently 
described. These tissues were then homogenized in 0.85^ 
sterile saline in a Sorvall Omni-Mixer Homogenizer with 
micro-homogenizer attachment. Homogenization was generally 
accomplished in 3 to 4 minutes at top speed in the micro-
homogenizer attachment. These samples were centrifuged at 
12,350 X G for 30 minutes at 2 C in the Sorvall RC2-B 
centrifuge to settle particulate material. A volume of 
0.2 ml of the supernatant material was inoculated peritoneally 
into an albino mouse. A second 0.2 ml of the supernatant 
material was mixed with an equal volume of type A antiserum 
and inoculated peritoneally into a white mouse. Death of 
the mouse not receiving the toxin-antitoxin mixture was 
considered to be caused by toxin extracted from the tissues. 
The remaining supernatant fluid was then treated with cold 
3^ trichloroacetic acid and allowed to precipitate for 3 
hours at 4 C. The material was centrifuged at 12,350 x G 
for 30 minutes at 2 C in the Sorvall RC-2B centrifuge to 
insure,separation of supernatant from precipitate. 
Supernatant, precipitate and particulate material were 
transferred to counting tubes and counted in the Picker 
counter. This procedure was performed in order to determine 
whether the radioactivity in the tissues was protein bound 
or in free or amino acid bound form at the time of death of 
the rat. 
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Determination of Purity of Toxin 
The exact purity of botulinal toxin supplied by Dr. 
Edward Schantz is unknown. Purified crystalline type A toxin 
is reported by Schantz (1964) to be 98^ pure. Toxin used 
in this work was analyzed for major impurities by using 
electrophoretic techniques. 
Agar gel was used in the electrophoretic procedure. 
Speical Agar Nobel (Difco), was dissolved in pH 7.8 borate 
buffer. , The concentration of agar used was 0.75 grams per 
100 ml of buffer. Twenty-five ml of melted agar were 
pipetted onto a lantern slide and allowed to harden. A 
paper wick saturated with botulinal toxin was inserted into 
the agar either in the center or 1 cm from the positive pole 
of the lantern slide. The slide was then placed in a 
Beckman Splnco paper electrophoretic apparatus. Borate 
buffer pH 7.8 was placed in the buffer tanks on either side 
of the electrophoresis apparatus. Filter paper wicks were 
attached to either side of the slide and allowed to extend 
into the buffer reservoirs. A Beckman power supply was used 
to provide the electrical potential. Using constant current 
a setting of 3 milliamperes and 18O volts was applied. The 
wick containing the toxin was removed from the agar after 
30 minutes at this power setting. The electrical potential, 
was then maintained for 18 hours. This allowed for a 
migration of 2.5 cm from the sample slot. The plate was then 
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stained with Amido Schwartz stain (National Analine, New 
York) and destained with a solution consisting of 2 parts of 
methanol, 2 parts of distilled water and 0,45 parts of 
glacial acetic acid. 
Autoradiography-
Autoradiography experiments were performed in an attempt 
to locate any large concentrations of radiolabeled botulinal 
toxin in the alimentary canal of a rat which had died of 
botulinal poisoning. A lethal dose of radiolabeled toxin 
was placed on a piece of bread along with peanut butter and 
fed to a rat. Upon death of the animal the alimentary canal 
was removed from esophogus to anus and laid out on Kodak 
RP 5^ Xray film. An aluminum foil envelope was used to 
protect the film from light. The digestive tract was 
allowed to remain on the film for varying periods up to 
eight hours to obtain good film exposure. A polaroid 
photograph was taken of the tissue layout so that the exposed 
portion of the film could be correlated with the tissue 
location. 
The film was processed by the Student Health Service, 
Iowa State University and examined for the presence of dark 
areas which indicated the localization of radioactive 
material in the digestive tract. 
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Detection of Radioactive Material in Animal Tissues 
Distribution patterns in rat tissues were established 
using the radiolabeled proteins. Two patterns were 
established using bovine serum albumin and rat serum albumin. 
A third pattern was established for purified type A 
botulinal toxin. The fourth pattern was determined for 
purified type A botulinal toxin introduced into rats which 
had received 0.6 International Units (lU) of type A antitoxin 
24 hours earlier. The antiserum was introduced by intra­
muscular injection into the hind leg muscle of the rat. 
With each distribution pattern determination l4 female 
albino rats were used. The rats which averaged in weight 
from l40 to l60 grams were obtained from Simonsen Labora­
tories, White Bear, Minn. Two rats were used for each 
sampling period. The sampling periods were 1, 2, 4, 8, 12, 
24 and 48 hours from the time of introduction of the radio­
labeled protein into the animals. In each determination 
the rats were anesthetized with ether and the radiolabeled 
protein was introduced by intraperitoneal inoculation. 
Sampling began 60 minutes after the last pair of rats was 
inoculated. 
At each sampling period two rats were anesthetized with 
chloroform and exsanguinated by cardiac puncture. The 
animals were then stretched out on a small animal operating 
board and opened ventrally from chin to tail. The following 
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tissues were removed: brain, lymph node in neck area, 
thyroid gland, blood, heart, lung, diaphragm, liver, spleen, 
kidney, stomach, small intestine, a portion of the spinal 
column containing muscle tissue, bone and central nervous 
cord, and finally the last 3 to 4 cm of the tail. As each 
tissue was removed it was placed in a disposable 5 ml 
microbeaker. After the tissues from both animals were 
removed they were weighed. 
The tissue samples contained in the microbeakers were 
folded and dropped into the bottom of the glass counter 
tubes and counted twice for periods of 60 seconds in the 
Picker counter. At the beglnnihg of the counting periods 
the counter was allowed to count an empty tube for 10 
minutes. This count divided by 10 was the background count 
which was then automatically subtracted from each of the 
successive counts by the Picker counter. The pair of values 
counted for each sample were averaged together at the end 
of the counting cycle. The average value for each of the 
samples was multiplied by a decay factor number. This 
number was obtained from the formula (Log —) where 
H t2 
t = the amount of time in hours from the time the radioisotope 
was made up until it was counted. This time value in 
Greenwich Mean Time (GMT) was given on each isotope container. 
The t|- value is the half life of the isotope. In the case 
of Iodine 131 ta = 8.05 days. After the count had been 
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corrected for decay factor It was divided by its tissue 
weight to obtain count per minute per gram of tissue. This 
value is the specific count of the tissue. The specific 
counts for each of the tissues from the duplicate animals 
in each sampling period were averaged together to obtain the 
average specific count for the pair of rats. 
A volume of radiolabeled protein material equal to the 
volume used for injection of each of the animals was counted 
along with the tissue samples. This sample was used to 
determine the total number of counts received by each animal 
in each distribution pattern determination. This value was 
constant within treatment groups since all the animals 
received equal volumes of material, but varied among treatment 
groups. The value which was called the total radioactive 
doses per animal was used to correct all specific counts 
statistically in such a way that all animals in all treatment 
groups received theoretically equalized radioactive doses. 
Statistical adjustments were calculated using analysis of 
covarlance. The reader is referred to Snedecor (1956) 
chapter 13 for formulae and directions for calculation of 
covarlance. 
31 
RESULTS AND DISCUSSION 
Radiolabeling of Proteins 
Radioactive iodine 131 was coupled to the proteins used 
in this study so they could be easily detected in animal 
tissues. The radiolabeling procedure was satisfactory for 
obtaining biologically active toxin and serum albumins with 
high radioactive counts. The method was simple and direct 
with the entire procedure consuming no more than 6 hours. 
Time is an important fac.tor when using an isotope of short 
»* 
half life such as iodine 131 for radiolabeling. The addition 
of iodine to toxin solutions did cause significant loss in 
biological activity. The magnitude of loss of toxicity will 
be discussed in a subsequent section. Less harm was done 
to the toxin when both the iodine and the toxin solution 
were chilled to 4 C before mixing and the incubation of the 
combination was carried out at 4 C. 
Filtration through Sephadex G50 was effective and rapid 
in removing the unbound iodine from the toxin solution. 
Figure 2 shows that when the number of milliliters collected 
from the column was plotted against the count for each 
fraction two distinct fractions were detected. The first 
peak which occurred between the l6th and 24th milliliters 
was equivalent to the void volume of the column as determined 
with dextran blue. The second peak which occurred between 
Figure 2. Filtration of radiolabeled protein material 
through Sephadex G50. The number of 
milliliters eluted from the column Is 







the 36th and 48th milliliters moved more slowly In the coliimn, 
and apparently contained material with a molecular weight 
less than the exclusion limit of Sephadex G50. 
Figure 3 displays the plot of the number of milliliters 
eluted from the column against the absorbance at 28o mu as 
measured on the Beckman DU. The absorbance peak occurring 
between the l6th and 24th milliliters corresponded exactly 
with the first count peak In Figure 2. The first count peak 
evidently contained protein material with radioactive Iodine 
bound to It. 
The tightness of the bond between the protein and the 
iodine was demonstrated using trichloroacetic acid precipita­
tion techniques. Bovine serum albumin and toxin to which 
radioactive iodine was bound were precipitated with cold 30 
trichloroacetic acid. The supernatant and precipitate were 
collected and counted separately. The precipitated bovine 
serum albumin contained 99.50 of the radioactivity while 
95.00 of the activity remained with the precipitated toxin. 
This demonstrated that the iodine was sufficiently tightly 
bound to the protein to withstand precipitation in trichloro­
acetic acid and did not dissassociate to any extent. Iodine 
131 has been used successfully by other workers to radlolabel 
proteins and toxins for jjn vivo and vitro immunological 
studies (Masouredls ^  1951J Tekman and Dalglish, 
1954; Melcher et ^1., 1955J Francis e^ , 1955a, b; Welgle 
Figure 3. Filtration of radiolabeled protein material 
through Sephadex G50. The number of 
milliliters eluted from the column Is 
plotted against the absorbanoe at 280 MU 




and Dixon, 1959; Welgle et aA., i960 and Klrllenko _et al., 
1965). 
LDr-n Determinations 50 
The biological activity of botullnal toxin type A was 
reduced by the radlolabellng procedure from 315,000 mouse 
units of toxin per ml to 315 mouse units per ml when iodine 
131 was used as the radlolabel. This amounted to a reduction 
factor of 10^ in biological activity. A precipitate formed 
in the toxic solution after iodine was added and the sample 
was Incubated for several hours at 4 C. The precipitate did 
not form 'in the toxic solution into which no iodine was 
added. Brazls _et (1959) reported that iodine in con­
centrations of 7.7 mg per liter of water was able to , 
biologically Inactivate 99.99# of partially purified type A 
botullnal toxin. In this Instance, the toxin was reported 
to be inactivated in 60 seconds at pH 6.25 when the sample 
was Incubated at 25 C. The actual amount of iodine on a 
weight per volume was not known since the radioactive iodine 
sample was calibrated only in terms of total activity in 
mllllcuries (mc); however, it was much less than the amount 
of Iodine used by Brazls e_t (1959). 
Despite the heavy loss of biological activity enough 
toxin was present initially in the concentrated purified 
sample to obtain a toxic solution with moderate biological 
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activity and high radioactivity after radiolabeling. The 
biological activity of the radiolabeled toxin sample used 
in the tissue distribution patterns was approximately 1000 
mouse units per ml of solution. 
Elimination Rate Determination 
The toxin used for elimination studies was placed in a 
food sample which would be readily eaten by the rats and 
which would provide protection for the toxin. As reported 
earlier by Coleman (1954), pure toxin is partially destroyed 
when fed to animals without protective colloids present. 
Table 3 shows the percent of total orally fed radioactive 
toxin excreted, from the rats in urine and feces. Non-Immune 
rats eliminated 63% to 70.5^ of the total radioactivity in 
a period of 48 hours. Passively Immune rats in the experl-
II 
ment excreted the radiolabeled toxin more rapidly than the 
non-immune animals; after 24 hours 70^ to 73% of the total 
activity was eliminated from the Immune rats and after 48 
hours the immune rats had eliminated 83% to 88$. Thus 
immune rats eliminated approximately the same amount of 
activity in 24 hours that was eliminated in 48 hours from 
non-Immune rats. 
The passively Immune rats were Inoculated Intramusculary 
with type A antiserum 24 hours prior to ingestion of the 
toxin. This time period was assumed to be sufficiently 
long to allow circulation of the antitoxin throughout the 
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Table 3. Elimination of orally fed botulinal toxin from 
rats. Elimination values are in percent of 
total dose given to each animal 
Time in Hours Rat 1 Rat 2 
Non-Immune Rats 
12 30# 31# 
24 50# 55# 
36 5f% 62# 
48 70.5# 
Immune Rats 
12 32# 31# 
24 73# 70# 
36 8l# 77# 
48 88# 83# 
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animal. Specific antibody would then be available to complex 
with the toxin which had been ingested and absorbed into 
the rat's circulation. The toxin-antitoxin complexes which 
formed in the animal were probably phagocytized. Phagocytic 
products probably included amino acids and short peptides 
containing radioactive iodine. These materials were excreted 
in the urine and feces of the rats. Degradation of toxin 
in the presence of specific antibody by phagocytosis may 
explain the increased rate of elimination of radiolabeled 
toxin from the passively immunized rats. 
Cells responsible for phagocytosis are microphages 
and macrophages. Microphages include the polymorphonuclear 
leucocytes of the blood. Macrophages comprise the cells of 
the reticuloendothelial system and are represented by both 
fixed and wandering cells. Fixed macrophages line the 
endothelium of capillaries and of the sinuses of organs such 
as the spleen, bone marrow and lymph nodes. Wandering 
macrophages such as monocytes migrate through tissues and 
are not localized to one particular tissue. The liver also 
possesses phagocytic properties (Carpenter, 19^5)• These 
tissues did not localize higher amounts of radioactive toxin 
in the passively immunized animals than did non-immune 
animals in this work. 
Treatment with trichloroacetic acid indicated less 
than 1.0^ of the total radioactivity found in urine samples 
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was précipitât able. Radioactive iodine was probably not 
attached to protein, but rather to breakdown products such 
as amino acids and short peptides. No attempt was made to 
determine if urine and feces contained biologically active 
toxin in quantities lethal to mice. 
The difference in excretion rates between rats which 
had been fed radioactive bovine serum albumin and Intraperi-
toneally inoculated with the same material can be seen in 
Figures 4 and 5. The specific counts for urine and feces 
from rats fed radiolabeled BSA were much higher than the 
specific counts for excretory products from perltoneally 
inoculated rats. Higher concentrations of radioactive 
material were present in the excrement of rats fed the 
radiolabeled protein. Animals fed the radiolabeled protein 
apparently degraded and excreted the material In a shorter 
time than the animals which received protein by Intra­
peritoneal inoculation. These observations were made with 
bovine serum albumin and not toxin. If the assumption was 
made, however, that radiolabeled toxin behaved in the same 
manner, it would explain why peritoneal doses of toxin were 
more potent than oral doses. The rats were able to digest 
and excrete a greater amount of the oral dose than the 
peritoneal dose of type A botulinal toxin. 
Figure 4. Specific counts for urine and feces of rats given oral doses of 
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Figure 5- Specific counts for urine and feces of rats given peritoneal doses 
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Toxin Recovery from Tissues 
The rats into which the radiolabeled toxin was inocu­
lated died within 6 hours. The results of the experiment 
are seen in Table 4. Only extracts from one tissue, the 
blood sample, produced death in mice when Inoculated 
peritoneally. Mice protected with specific antitoxin 
survived; thus, it was concluded that toxin was present in 
lethal quantities in the rat's blood. The reason for recovery 
of biologically active toxin from blood only is not clear. 
Toxin may have been liberated more easily from the blood 
because the sample was fluid and therefore much easier to 
homogenize. The homogenization of tougher tissues may have 
caused biological inactivation of the toxin. Toxin may not 
be readily freed from solid tissue as was the case for the 
fluid blood sample. Dack (1926) observed little toxic 
activity in the blood of rats which were fed large doses, 
but he did find toxin in the blood of rats inoculated 
peritoneally. 
The counts for particulate material which settled after 
homogenization and the first centrifugation, the tricholoro-
acetic acid precipitated homogenate and the non-precipitated 
supernatant, suggested that in most of the tissue sampled 
the largest portion of the radioactivity was found either 
in the particulate or trichloroacetic acid precipitated 
material. Possibly, the radioactivity was still bound to 
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Table 4. Biological activity and distribution of radio­
active material from tissue homogenates. All 
values are averages for two animals 
Tissue Weight Particular Precipitated Supernatant Toxic 
in material material count to 
grams count count mice 
Blood 1.388 4l80 1400 1840 + 
Heart 0.855 830 250 350 -
Lung 1.515 1430 180 860 -
Diaphragm 0.417 5710 220 2740 -
Liver 2.644 850 304o 850 -
Spleen 0.484 110 210 540 -
Kidney 1.048 1510 340 880 -
Stomach 2.719 24250 430 1532 -
Small 
Intestine 1.244 360 180 1040 -
Spinal 
Column 1.392 570 120 500 -
Thyroid 0.071 6510 10220 500 -
Lymph Node 0.115 220 110 l4o -
Brain 1.617 100 50 90 -
Tall 0.473 3000 -
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protein. The small Intestine appeared to he an exception to 
that observation. Most of the radioactivity for this parti­
cular tissue was found in the supernatant. The thyroid 
gland, in which one would expect to find free iodine revealed 
very little radioactivity in non-precipitated material. 
The degree of homogenizatlon depended on the elasticity 
and toughness of the tissues. Soft tissues like blood, 
lung, liver, small Intestine and brain allowed more complete 
homogenizatlon than the stomach, spinal column and tall. 
After several minutes homogenizatlon at top speed on the 
Sorvall homogenizer these tissues were still In a chunk 
state Instead of a smooth homogeneous mixture. The tail 
was too tough to be broken up by the homogenizer and thus 
the entire structure was counted and recorded as particulate 
count. No tissue extract from the tail was obtained. 
Trichloroacetic acid generally causes precipitation of 
proteins by forming insoluble salts with them (White et al., 
1964). This procedure using trichloroacetic acid was de­
signed to show to what extent the radioactivity was associated 
with preclpltatable protein molecules. Assuming that type A 
botulinal toxin has a molecular weight of 900,000 and is 
completely precipitated by trichloroacetic acid, the extent 
of its breakdown into small non-precipitatable products 
within the tissues sampled could be determined by this 
procedure. Since the molecular weight of type A toxin is 
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unknown when circulating throughout an animal, the possi­
bility exists that biologically active toxin was present 
in the tissues, but was too small to be precipitated with 
trichloroacetic acid. Wagman (1963) reported a type A 
botulinal toxin sub-unit with a weight of 3,800 which still 
possessed biological activity. Heckly et (1960) 
found no evidence that type A botulinal toxin broke down 
into sub-units in the intestine of a rat. Schantz and 
Spero (1966) insisted that the weight of type A toxin was 
900,000 and the purity of the toxin was not a significant 
factor in molecular weight determinations. Disagreement 
about the molecular weight of botulinal toxin has been 
previously discussed in the literature review. 
The radioactive material found in the non-precipitatable 
samples might have been amino acids and short peptides to 
which iodine was bound. These materials were probably from 
the degradation of the botulinal toxin in the rat's body. 
Ability of the rat to excrete large quantities of radio^ 
active material in the urine indicated that the toxin was 
being broken down into excretable products. 
Determination of Purity of Toxin 
Gel electrophoresis was used to determine if any major 
impurities were present in the purified botulinal toxin used 
in this work. Only one band was visible by this technique 
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after l8 hours continuous application of electrical potential 
(Figure 6). The toxic material migrated slowly and was 
about 2.5 cm from the sample slot after l8 hours. Since 
only one band was present it was concluded that either no 
major impurities existed in the toxin sample, or the methods 
used were not sufficient to promote separation. One of the 
unexplained aspects of this experiment was the observation 
that the toxin sample migrated toward the cathode. The iso­
electric point for botulinal toxin was reported by Schantz 
(1964) to be at pH 5-6. At pH values above this, such as 
the pH of the buffer system used in the electrophoresis 
(pH 7.8) the toxin molecules should have had a negative 
charge and migrated towards, the anode. 
One explanation for the phenomenon is that the material 
was not toxin but some other protein with different electrical 
properties. The sample, however, was lethal to mice and 
type A antitoxin protected the mice. Another suggestion is 
that the isoelectric point of botulinal toxin is not at pH 
5.6 as previously reported, but at a value above pH 7.8. 
The ionic strength and pH of the buffer system used may have 
caused the toxin to aggregate or disassociate in such a 
manner as to change the isoelectric point. Insufficient 
experimental work was done to legitimately challenge the 
established Isoelectric point of crystalline, type A 
botulinal toxin and so this argument will not be promoted. 
Figure 6. Electrophoresis plate used in toxin purity 
determination. Black bar indicates point at 
which sample was applied. One protein band 
is seen approximately in the center of the 
slide, 2,5 cm from the sample slot. The 
electrical poles are indicated on the slide 
by the symbols + and 
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A third suggestion is that the 0.05 M sodium phosphate 
buffer at pH 6.8 in which the toxin was lyophllized may 
Interfere with the electrical properties of the toxin. 
Perhaps some hydrogen ion from the phosphate buffer was 
able to cling tightly enough to the toxin even in a sodium 
borate pH 7.8 system to impart a net positive charge to the 
toxin molecules causing the toxin to migrate towards the 
anode in a pH 7.8 system. 
Autoradiography 
Poor results were obtained in the autoradiography 
experiment. The first animals examined died l8 to 20 hours 
after ingesting the toxin and the autoradiographs displayed 
no evidence of localization of radioactivity In any portion 
of the digestive canal. During a second attempt, large 
doses of toxin were fed to the rats. These animals died 
within 7 hours and large amounts of radioactivity were 
found in the stomach and small intestine. The film was 
exposed underneath and approximately 2 to 3 cm on either side 
of the tissues and it was difficult to relate the location 
of the radioactivity with the location of the parts of the 
digestive system. This overexposure was caused in part 
by the long range high energy characteristics of the gamma 
radiation emitted by iodine 131. Because of the brief 
period between ingestion of the toxin and death, it could 
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not be concluded from the autoradiographs that the toxin was 
actually absorbed into the stomach and intestinal tissues. 
Examination of the stomach contents of one of these rats 
after death revealed that much of the peanut butter and 
bread on which the toxin was mixed prior to ingestion was 
still in the stomach. 
Determination of Radioactive Material in Animal Tissues 
All of the distribution patterns were determined with 
proteins that were inoculated peritoneally into rats. The 
normal route of entry of toxins and proteins into an 
animal's body is by the oral route. Nevertheless, this 
method of inoculation was used because of ease of intro­
ducing the radiolabeled material into a number of animals 
within a short period of time and of assurance that equal 
volumes of protein were received by each animal. Feeding 
radiolabeled proteins to rats was unsatisfactory because 14 
rats would not eat equal amounts of material simultaneously. 
Often one or more hours elapsed between the time that the 
animals received the sample until all had consumed it. 
Introducing radiolabeled material into rats by stomach tube 
sometimes allowed a portion of the sample to be forced back 
up the esophagus and into the trachea and lungs. In 
addition, this method was found to be much too slow when 
large numbers of rats were Inoculated. 
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To Insure survival of all animals through the 48th hour 
of sampling a sublethal dose of toxin was given. Twice the 
amount of toxin given to the rats in this experiment consti­
tuted a lethal dose. 
The total amount of radioactive material localized per 
gram of tissue during the seven sampling periods can be 
seen in Table 5. The group of rats receiving bovine serum 
albumin had high total localization of radioactivity in the 
thyroid gland, intestine, blood and diaphragm. Lesser 
amounts of radioactivity were accumulated in the spleen, 
kidney, stomach, lung, heart and tail. The tissues which 
accumulated the least radioactivity were the spinal column 
and brain. Radiolabeled rat serum albumin was found to 
localized in relatively high concentrations in the thyroid, 
stomach, kidney, spleen, blood, diaphragm and intestine. 
Less total localization was found in the liver, tall, heart 
and lung. Little accumulation of activity was found in the 
spinal column, lymph node and brain. The rats into which 
radioactive toxin was inoculated localized high amounts of 
activity in the thyroid, stomach, diaphragm, blood and 
spleen. The kidney, tall, liver, heart, spinal column and 
lung had less total accumulation. Localization of radio­
active material was slight in the lymph node and brain. 
Passively Immunized rats into which toxin was injected had 
high total localization of radioactivity in the thyroid. 
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Table 5. Total specific counts for tissues 













































































stomach, blood, tail, diaphragm and spleen. Less activity 
was accumulated in the liver, intestine, heart, spinal column, 
kidney and lung. Small amounts of radioactive material were 
found in the lymph node and brain. 
Radioactivity from the non-toxic and toxic proteins 
localized to a high degree in the thyroid, blood and 
diaphragm. Although localization was less pronounced for 
the group of rats receiving bovine serum albumin, all groups 
accumulated relatively high total specific counts in the 
stomach, spleen, intestine and tail. Very little localization 
occurred in the lymph node or brain with any of the groups. 
The main observable effect of passive immunity was 
the markedly reduced magnitude of the count in tissues such 
as the stomach, spleen, intestine diaphragm and thyroid 
over that observed for the non-immune rats which received 
only toxin. Data on excretion by immune and non-immune 
animals may partially explain this observation. The values 
reported by Kirllenko _et 1965 for radiolabeled tetanal 
toxin in tissues were similarly reduced when animals were 
passively Immunized prior to injection of toxin. 
The distribution patterns shown in Figures 7 through l4 
display many similarities among the four groups. The 
diaphragm and spleen in the four treatment groups have 
similar distribution patterns. The highest specific count 
for these tissues was observed at the one hour sampling 
period and the counts decreased with each successive sampling. 











Figure 9. Tissue distribution patterns for rats receiving botulinal toxin. 
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Figure 11. Comparison of distribution patterns for the blood, heart, lung and 
diaphram of rats receiving bovine serum albumin, rat serum albumin, 









r 2 4 a 12 244* I 2 4 a 12 2448 
TIME 1 2 4 8 12 24 48 1 2 4 8 12 2448 I 2 4 8 12 2448 I 2 4 8 12 24 48 
HRS. BLOOO HEART LUNG DIAPHRAGM 















2 * * *2 24 48 I 2 4 a 12 24 48 I 2 4 8 )2 24 48 I 2 4 8 12 24 48 
M»» BLOOD HEART LUNG MAPHRAGU 
cr\ 
Figure 12. Comparison of distribution patterns for the liver, kidney, spleen and 
stomach of rats receiving bovine serum albumin, rat serum albumin, 
toxin and toxin plus antitoxin. 
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Figure 13. Comparison of distribution patterns for the Intestine, spinal 
column, lymph node and brain of rats receiving bovine serum 




Figure 14. Comparison of distribution patterns for the tail and thyroid of rats 





This same general pattern was observed for the Intestine In 
the groups of rats Inoculated with radioactive serum albumin. 
The intestines of rats receiving toxin did not contain high 
amounts of radioactivity in the first sampling period, but 
the activity rose rapidly to a peak at 2 hours. The counts 
for each successive time period were reduced respectively. 
Blood, heart, lung, liver, stomach and tail displayed similar 
distribution patterns for all rats. Radioactive counts 
generally increased to a peak value at either 2 or 4 hours 
then declined during successive sampling periods. This 
pattern was duplicated for the kidney and spinal column In 
all but the group receiving antitoxin and toxin. In the 
passively Immunized group of rats the highest degree of 
localization In these tissues occurred during the first 
hour and the count declined with successive sampling periods. 
The concentration of radioactive material localized in the 
thyroid gland increased steadily through the 24 hour sample 
and through the 48 hour for the rats receiving bovine serum 
albumin. The general distribution patterns were similar 
for all rats In all groups of rats. 
Significance of Localization Patterns in Rat Tissues 
Caution must be observed in interpreting data from this 
type of experiment. Biological variability is a major source 
of error when working with biological systems. Occasionally 
i 
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identical organs taken from a pair of rats in a sampling 
period varied greatly in the amount of radioactivity localized 
within them. The animals were simultaneously inoculated 
peritoneally and killed at the same time. The entire organ 
was removed and in most cases the weights were nearly equal, 
yet one organ would demonstrate a high count while the other 
had a low count. Since only two rats were used in each 
sampling period an insufficient number of samples was 
available to calculate an estimation of variance. The 
counts reported on the bar graphs were averages which were 
greatly influenced by unusually high or low tissue radio­
activity in a sampling period. The variations in specific 
count for a tissue where one count dropped below the 
values on either side of it as observed in Figure 7 is an 
example of the effect of biological variability. 
Counting error is another factor which must be con­
sidered. Nuclear decay is a random process and a sample 
will rarely yield the same value when counted repeatedly 
for equal time periods. Long counting periods reduce the 
magnitude of error. Standardization of counting techniques 
allowed this type of error to become relatively constant 
which theoretically subjected all data to the same general 
magnitude of error. 
The specific count for organs or tissues with high 
radioactive content and low weight, such as the thyroid 
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gland, were effected greatly by weight variations. The 
specific count for a thyroid gland could be reduced by 100^ 
by changing the weight from O.05 grams to 0.10 grams. Since 
the thyroid In a rat Is very small, the larynx-thyroid 
complex was removed and counted as a unit. An additional 
0.05 gram of tissue could easily have been carried along 
with the thyroid gland and caused this type of error. 
When protein materials are perltoneally Inoculated Into 
an animal, they gain entry Into the general circulation by 
way of the lymphatics draining Into the thoracic duct which 
In turn drains Into the subclavian vein (Raffel, 1961), 
The blood samples contained relatively high amounts of 
radioactivity shortly after peritoneal inoculation of the 
rat. Since the proteins were Inoculated Into the peritoneal 
cavity, an initially high concentration of radioactivity 
might be expected to be associated with the intestine because 
of adsorption of radioactive material onto this tissue at 
the Injection site. This author cannot explain why rats 
which received toxin did not localize high amounts of 
radioactivity in the Intestine during the first hour as did 
animals receiving serum albumin. Relatively high amounts of 
radioactive protein localized in the spleen within the 
first hour in all treatments. The spleen is one of the main 
filters in the circulatory system and is Important in 
destruction of foreign material such as bacteria and worn 
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out blood cells (Romer, 1962). This may explain the 
initially .high concentration of activity in this tissue. 
The reason for the diaphragm following this same pattern 
is not clear, but it's location in the body cavity may have 
permitted absorption of large amounts of peritoneally 
injected protein within the first hour. Large amounts of 
radioactive material located In the tissues of the stomach 
in many of the rats. Again the reasons for concentration of 
radioactivity in this tissue and not In the surrounding 
tissues is not understood. Large amounts of radioactivity 
were observed In the tip of the tall. This structure is 
composed mostly of bone and collagen (Greene, 1935). Perhaps 
the combination of material was effective in retaining 
radioactive proteins or their breakdown products. The 
highest specific count for any tissue was obtained for the 
thyroid glands in the rats. An examination of the bar graphs 
reveal that counts in excess of 500,000 were obtained for 
these glands. The patterns were generally similar in the 
fours treatments with a steadily rising count through the 
24th hour. This tissue has an affinity for accumulating 
iodine (Romer, 1962). As the protein material broke down 
in the animal the lodlnated products including amino acids 
and short peptides apparently localized in the thyroid. 
Very little radioactivity was found in either the brain or 
lymph nodes of the rats sampled. The radiolabeled proteins 
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either did not enter or were not retained in these tissue 
to any great extent. 
The distribution patterns obtained for the toxic and 
non-toxic proteins appear to have more similarities than 
differences. Bovine and rat serum albumins, although the 
former is foreign while the latter is native to the rat, 
displayed almost identical distribution patterns. These in 
turn were similar to the patterns obtained for sublethal 
doses of toxin. The specific effect of passive immunity 
was a reduction of specific count values for some tissues 
over the counts obtained for the same tissues in rats 
receiving only toxin. The patterns obtained for immune 
animals retained many similarities to the other distribution 
patterns. No outstanding differences existed between the 
distribution patterns observed for toxin and nontoxic 
albumins. Other methods of Inoculation such as Intravenous, 
Intramuscular, or oral may have produced distribution patterns 
differing from the ones observed for peritoneally inoculated 
proteins. 
Alternate methods of radiolabeling might be more 
suitable for this type of study. For example, botulinal 
toxin with carbon l4 integrated into the carbon chain 
structure might be used to determine the fate of radio­
labeled botulinal toxin within the animal body. With the 
radiolabel being an integral part of the toxin molecule 
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there would be no concern about the effect of adding iodine 
to toxin, or to the tightness of the bond between iodine 
and toxin once the protein was introduced into the animal. 
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CONCLUSIONS 
1. Purified "botulinal toxin can be radiolabeled with 
iodine 131 using isotopic exchange methods. The biological 
activity of the toxin, however, was reduced by a factor of 
103 by the radiolabeling procedure. 
2. The distribution of botulinal toxin within animals 
into which this material was inoculated was found not to 
be unique to the toxin, but similar to distribution patterns 
obtained for nontoxic serum proteins. Large amounts of 
radioactivity were found in the thyroid, blood, diaphragm, 
stomach, spleen, intestine and tail oj^most rats in all 
groups. Very little localization occurred in the lymph node 
or brain in any of the rats. 
The main effect of passive immunity was a reduction in 
the degree of localization of radiolabeled toxin in the 
stomach, spleen, diaphragm, intestine and thyroid of the 
rats. Only the magnitude of localization, not the distri­
bution patterns, was effected appreciably by passive 
immunization. 
3. Large amounts of orally fed radiolabeled botulinal 
toxin were excreted by rats within 48 hours. Passively 
Immune rats excreted in 24 hours the same amount of radio­
active material excreted in 48 hours by non-immune rats. 
Orally fed, radiolabeled protein is excreted more rapidly 
by rats than the same material Inoculated intraperltoneally, 
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SUMMARY 
Botulinal toxin type A was obtained in pure form from 
Dr. Edward Schantz. The toxin was radiolabeled with iodine 
131 using an isotopic exchange reaction. A small crystal of 
elemental iodine was added to a solution of sodium iodide 131 
and allowed to react for 20 minutes. Free iodine 131 was 
obtained in the solution which was then added to the toxin; 
the mixture of toxin and radioactive iodine was incubated 
at 4 C for 4 hours. The unbound iodine was removed by 
filtration through Sephadex G50. Bovine serum albumin and 
rat serum albumin were also labeled by this procedure. 
Radiolabeled toxin was fed to non-immune and passively 
immunized rats and their excretory products were collected 
and counted at 12 hour intervals for a period of 48 hours. 
Excretory rates were reported in terms of percent of the 
total ingested radioactive material eliminated by the rats 
during each 12 hour period. Passive immunity apparently 
speeds up the rate of excretion of toxin. A large percentage 
(70$ to 73^) of the radioactive material was excreted by 
the passively immunized animals within 24 hours; in non­
immune animals, the time required for elimination of a 
similar amount was 48 hours. 
Distribution patterns were established for radiolabeled 
bovine serum albumin, rat serum albumin, botulinal toxin 
type A and botulinal toxin type A given to animals which were 
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passively Immunized with type A antiserum. Fourteen rats 
were used in each distribution pattern determination. The 
animals were inoculated Intraperitoneally with the radio­
labeled material and two animals were sacrificed at each of 
the following time periods: 1 hour, 2 hours, 4 hours, 8 
hours, 12 hours, 24 hours and 48 hours after injection. The 
following tissues were removed, weighed and analyzed for 
radioactivity: brain, lymph node in neck, thyroid gland, 
blood, heart, lung, diaphragm, liver, kidney, spleen, 
stomach, intestine, spinal column and tip of the tail. 
These tissues were analyzed for radioactivity in a Picker 
Autowell II gamma radiation counter. Tissue counts were 
corrected for decay factor and divided by the weight of the 
tissue to obtain the count per minute per gram of tissue. 
The counts were treated statistically to enable direct 
comparisons of the specific counts for the tissues. The 
distribution patterns obtained for the groups of rats were 
generally very similar. Large amounts of radioactivity was 
found in the thyroid, blood, diaphragm, stomach, spleen. 
Intestine and tall of most rats. The main effect of passive 
immunity was to reduce the amount of localization of radio­
labeled toxin in the stomach, spleen, intestine and thyroid 
of the rats. 
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